Search Within

GME, Neurology

Formats
  1. Meeting Abstract (24)
  2. Journal Article (23)
  3. Review (8)
  4. Book Section (4)
  5. Correspondence (1)
Groups
  1. Graduate Medical Education (60)
  2. Department of Medicine (24)
  3. Biostatistics Service (21)
  4. Center for Pancreatic Cancer Research (21)
  5. Epidemiology and Biostatistics (21)
  6. Solid Tumor Oncology Division (21)

More Groups

People
  1. Alexandra Gewirtz (21)
  2. Nancy Kemeny (17)
  3. Maria Diaz Ordonez (16)
  4. Elena Pentsova (13)
  5. Michael D'Angelica (13)
  6. William Jarnagin (13)

More People

Years
  1. 2025 (1)
  2. 2024 (12)
  3. 2023 (13)
  4. 2022 (8)
  5. 2021 (5)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Neuro-Oncology (11)
  3. Cancer (4)
  4. American Journal of Physical Medicine & Rehabilitation (2)
  5. HPB (2)
  6. Neuro-Oncology Advances (2)

More Publications

Publishers
  1. Oxford University Press (15)
  2. American Society of Clinical Oncology (12)
  3. Lippincott Williams & Wilkins (6)
  4. Wiley Blackwell (6)
  5. Springer (5)
  6. Elsevier Inc. (3)

More Publishers

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of KRAS mutation with worse recurrence-free survival and site of metastatic progression after resection of hepatic colorectal metastases
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
    Journal Article

    Matasar, M. J.; Czuczman, M. S.; Rodriguez, M. A.; Fennessy, M.; Shea, T. C.; Spitzer, G.; Lossos, I. S.; Kharfan-Dabaja, M. A.; Joyce, R.; Fayad, L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases
    Journal Article

    Ang, C.; Jhaveri, K.; Patel, D.; Gewirtz, A.; Seidman, A.; Kemeny, N.
    Breast Journal (2013)

    Fulltext@MSK | Save
  • Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM)?
    Meeting Abstract

    Kemeny, N. E.; Fong, Y.; Paty, P.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Jarnagin, W. R.; DeMatteo, R. P.; Allen, P. J.; Kingham, T. P.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?
    Meeting Abstract

    Kemeny, N. E.; Schwartz, L. H.; Gonen, M.; Yopp, A. C.; D'Angelica, M. I.; Fong, Y.; Haviland, D.; Gewirtz, A. N.; Allen, P. J.; Jarnagin, W. R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) in the treatment of breast cancer with liver metastases (BCLM) in patients (pts) who progressed after hormonal and systemic chemotherapy (CTx)
    Meeting Abstract

    Herran, L. A.; Jhaveri, K. L.; Seidman, A. D.; Patel, D.; Gewirtz, A. N.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?
    Journal Article

    Kemeny, N. E.; Schwartz, L.; Gonen, M.; Yopp, A.; Gultekin, D.; D'Angelica, M. I.; Fong, Y. M.; Haviland, D.; Gewirtz, A. N.; Allen, P.; more...
    Oncology (2011)

    Fulltext@MSK | Save
  • Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer
    Journal Article

    Kemeny, N. E.; Jarnagin, W. R.; Capanu, M.; Fong, Y.; Gewirtz, A. N.; DeMatteo, R. P.; D'Angelica, M. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion
    Meeting Abstract

    Power, D. G.; Capanu, M.; Patel, D.; Gewirtz, A.; Jarnagin, W. R.; Fong, Y.; D'Angelica, M. I.; DeMatteo, R. P.; Kemeny, N. E.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer
    Meeting Abstract

    Kemeny, N. E.; Jarnagin, W. R.; Capanu, M.; Fong, Y.; Gewirtz, A.; DeMatteo, R. P.; D'Angelica, M. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save